↓ Skip to main content

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Overview of attention for article published in The Lancet, October 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
10 news outlets
blogs
3 blogs
policy
2 policy sources
twitter
63 X users
patent
95 patents
weibo
12 weibo users
facebook
3 Facebook pages
wikipedia
4 Wikipedia pages
reddit
2 Redditors

Citations

dimensions_citation
2505 Dimensions

Readers on

mendeley
1611 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Published in
The Lancet, October 2014
DOI 10.1016/s0140-6736(14)61403-3
Pubmed ID
Authors

Daniel W Lee, James N Kochenderfer, Maryalice Stetler-Stevenson, Yongzhi K Cui, Cindy Delbrook, Steven A Feldman, Terry J Fry, Rimas Orentas, Marianna Sabatino, Nirali N Shah, Seth M Steinberg, Dave Stroncek, Nick Tschernia, Constance Yuan, Hua Zhang, Ling Zhang, Steven A Rosenberg, Alan S Wayne, Crystal L Mackall

X Demographics

X Demographics

The data shown below were collected from the profiles of 63 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1,611 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 8 <1%
United Kingdom 4 <1%
Netherlands 2 <1%
Belgium 2 <1%
Germany 2 <1%
Italy 1 <1%
Ecuador 1 <1%
Malaysia 1 <1%
Turkey 1 <1%
Other 7 <1%
Unknown 1582 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 274 17%
Researcher 240 15%
Student > Bachelor 207 13%
Student > Master 163 10%
Other 95 6%
Other 246 15%
Unknown 386 24%
Readers by discipline Count As %
Medicine and Dentistry 347 22%
Biochemistry, Genetics and Molecular Biology 274 17%
Agricultural and Biological Sciences 191 12%
Immunology and Microbiology 168 10%
Engineering 54 3%
Other 150 9%
Unknown 427 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 175. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 May 2024.
All research outputs
#234,763
of 25,837,817 outputs
Outputs from The Lancet
#2,650
of 43,003 outputs
Outputs of similar age
#2,148
of 270,062 outputs
Outputs of similar age from The Lancet
#36
of 567 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 43,003 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 270,062 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 567 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.